Loading
Total declarations
Company
▲ Purchases (22 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Dec 2025 for Silo Pharma, Inc., €873. Read the official filing
Filing timeline
BuySaleEric Weisblum
Insider track record
Disclosed buys
22
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+10.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Eric Weisblum: trading record in brief
Eric Weisblum, listed as chief executive, appears in our data through filings on Silo Pharma, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 17 June 2019 to 15 December 2025, the count stands at 23 filings.
The open-market record is one-sided, with 22 purchases worth €40k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant. So far in 2025, the count stands at 4 purchases and no sales.
The median purchase comes to €1,216. Across 21 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The latest filing, published on 16 December 2025, reports an open-market purchase of €873 in Silo Pharma, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Eric Weisblum
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
2,500 shares@ US$0.412.4% of flowCommon StockSEC:0001213900-25-122429:0
Canonical exit: 15 Mar 2026 (T+90)
1,000 shares@ US$0.370.9% of flowCommon StockSEC:0001213900-25-113743:0
Canonical exit: 18 Feb 2026 (T+90)
7,500 shares@ US$0.40337.5% of flowCommon StockSEC:0001213900-25-113104:0
Canonical exit: 16 Feb 2026 (T+90)
10,000 shares@ US$0.43299.6% of flowCommon StockSEC:0001213900-25-048304:0
Canonical exit: 25 Aug 2025 (T+90)
2,500 shares@ US$0.83876.1% of flowCommon StockSEC:0001213900-24-109363:0
Canonical exit: 13 Mar 2025 (T+90)
2,500 shares@ US$0.956.8% of flowCommon StockSEC:0001213900-24-101610:0
Canonical exit: 18 Feb 2025 (T+90)
562 shares@ US$1.081.7% of flowCommon StockSEC:0001213900-24-052354:0
Canonical exit: 9 Sept 2024 (T+90)
600 shares@ US$1.963.3% of flowCommon StockSEC:0001213900-24-031159:0
Canonical exit: 3 Jul 2024 (T+90)
3,408 shares@ US$1.9418.6% of flowCommon StockSEC:0001213900-24-028973:0
Canonical exit: 26 Jun 2024 (T+90)
500 shares@ US$1.632.3% of flowCommon StockSEC:0001213900-23-097689:0
Canonical exit: 18 Mar 2024 (T+90)
200 shares@ US$1.500.8% of flowCommon StockSEC:0001213900-23-096606:0
Canonical exit: 13 Mar 2024 (T+90)
600 shares@ US$1.392.3% of flowCommon StockSEC:0001213900-23-094145:0
Canonical exit: 4 Mar 2024 (T+90)
1,000 shares@ US$1.574.3% of flowCommon StockSEC:0001213900-23-091665:0
Canonical exit: 27 Feb 2024 (T+90)
400 shares@ US$1.681.9% of flowCommon StockSEC:0001213900-23-090270:0
Canonical exit: 20 Feb 2024 (T+90)
4,050 shares@ US$1.6018.1% of flowCommon StockSEC:0001213900-23-089570:0
Canonical exit: 18 Feb 2024 (T+90)
1,100 shares@ US$1.334.1% of flowCommon StockSEC:0001213900-23-088890:0
Canonical exit: 14 Feb 2024 (T+90)
2,500 shares@ US$2.0614.5% of flowCommon StockSEC:0001213900-23-041179:0
Canonical exit: 15 Aug 2023 (T+90)
200 shares@ US$2.68151.5% of flowCommon StockSEC:0001213900-22-081513:0
Canonical exit: 19 Mar 2023 (T+90)
487 shares@ US$3.06764.3% of flowCommon StockSEC:0001213900-22-080102:0
Canonical exit: 13 Mar 2023 (T+90)
13,080 shares@ US$0.11470.022% mcap47.4% of flowCommon StockSEC:0001213900-22-033752:0
Canonical exit: 15 Sept 2022 (T+90)
5,000 shares@ US$0.15541.7% of flowCommon StockSEC:0001213900-21-065395:0
Canonical exit: 10 Mar 2022 (T+90)
57,714 shares@ US$0.0020.3% of flowCommon StockSEC:0001213900-21-026675:0
Canonical exit: 15 Sept 2019 (T+90)
7,630,949 sharesCommon StockSEC:0001213900-21-026677:0
23 of 23 declarations
